Join us as Kelly Stone, MD, PhD, FAAAAI, explains the evolution of the U.S. Food and Drug Administration and its central role in ensuring the safety and efficacy of therapeutics in the United States. We discuss the modern drug approval process from preclinical development through clinical trials and post-marketing surveillance  and explore what makes this pathway different for biologics and biosimilars so you have a better understanding of the therapeutics that we prescribe every day in the clinic.

Biosimilars

MedWatch:The FDA Safety Information and Adverse Event Reporting Program

FDA History

Drug Development Process

Rss Apple Podcaster
Podden och tillhörande omslagsbild på den här sidan tillhör The American Academy of Allergy, Asthma & Immunology (AAAAI). Innehållet i podden är skapat av The American Academy of Allergy, Asthma & Immunology (AAAAI) och inte av, eller tillsammans med, Poddtoppen.